Who owns STRUCTURE THERAPEUTICS INC?
- Ticker: GPCR
- CUSIP Number: 86366e106
Tip: Access positions for across all investors
Analyze quarterly positions in Structure Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Structure Therapeutics stock
Who bought or sold STRUCTURE THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Wellington Management Company | 4.4M | $178M | 404% | Dec 2023 |
|
FMR | 2.9M | $126M | 85% | Mar 2024 |
|
venBio Select Advisor | 2.3M | $95M | 133% | Dec 2023 |
|
Federated Investors | 2.3M | $92M | 104% | Dec 2023 |
|
Henderson Group | 2.1M | $89M | 34% | Mar 2024 |
|
T. Rowe Price Associates | 1.6M | $67M | -7% | Mar 2024 |
|
RA Capital Management | 1.5M | $65M | 210% | Mar 2024 |
|
Citadel Advisors | 1.4M | $61M | 17% | Mar 2024 |
|
Alyeska Investment Group | 1.3M | $56M | 628% | Mar 2024 |
|
T. Rowe Price Investment Management | 1.2M | $52M | -23% | Mar 2024 |
|
Logos Global Management | 1.2M | $50M | 9% | Mar 2024 |
|
Casdin Capital | 1.1M | $48M | 0% | Mar 2024 |
|
BlackRock | 1.1M | $47M | 106% | Mar 2024 |
|
Sc China Holding | 1.1M | $38M | 0% | Mar 2024 |
|
Deerfield Management Company | 1.0M | $44M | 26% | Mar 2024 |
|
Avidity Partners Management | 1.0M | $44M | -40% | Mar 2024 |
|
BVF | 813k | $35M | 0% | Mar 2024 |
|
Adage Capital Partners GP | 811k | $35M | -55% | Mar 2024 |
|
Frazier Life Sciences Management | 629k | $27M | 98% | Mar 2024 |
|
Franklin Resources | 536k | $23M | -1% | Mar 2024 |
|
Susquehanna International | 508k | $22M | 100% | Mar 2024 |
|
Octagon Capital Advisors | 507k | $22M | 22% | Mar 2024 |
|
Goldman Sachs Group | 449k | $19M | 5% | Mar 2024 |
|
Braidwell | 436k | $19M | 56% | Mar 2024 |
|
Fred Alger Management | 413k | $18M | 42% | Mar 2024 |
|
Rock Springs Capital Management | 413k | $18M | 100% | Mar 2024 |
|
Boxer Capital | 400k | $17M | 0% | Mar 2024 |
|
Money Concepts Capital Corp | 377k | $16M | 100% | Mar 2024 |
|
Bellevue Group | 364k | $16M | 2859% | Mar 2024 |
|
Morgan Stanley | 294k | $13M | 1133% | Mar 2024 |
|
American Century Companies | 262k | $11M | 100% | Mar 2024 |
|
Arrowpoint Asset Management | 255k | $11M | -8% | Mar 2024 |
|
Caption Management | 183k | $7.8M | -75% | Mar 2024 |
|
Woodline Partners | 180k | $7.7M | 6% | Mar 2024 |
|
Artal Group | 152k | $6.5M | 75% | Mar 2024 |
|
First Light Asset Management | 149k | $6.4M | 100% | Mar 2024 |
|
TD Asset Management | 143k | $6.1M | -9% | Mar 2024 |
|
Candriam Luxembourg S.C.A. | 135k | $5.8M | -36% | Mar 2024 |
|
Ikarian Capital | 122k | $5.2M | 743% | Mar 2024 |
|
HAP Trading | 108k | $4.6M | 100% | Mar 2024 |
|
Tang Capital Management | 100k | $4.3M | 100% | Mar 2024 |
|
Walleye Trading Advisors | 100k | $4.3M | 100% | Mar 2024 |
|
Pier Capital | 98k | $4.2M | 174% | Mar 2024 |
|
Monashee Investment Management | 95k | $4.1M | -51% | Mar 2024 |
|
Millennium Management | 91k | $3.9M | -5% | Mar 2024 |
|
Ameriprise Financial | 91k | $3.9M | 100% | Mar 2024 |
|
Barclays | 90k | $3.9M | 10761% | Mar 2024 |
|
UBS Group | 83k | $3.5M | 39% | Mar 2024 |
|
Platinum Investment Mangement | 77k | $3.3M | 47% | Mar 2024 |
|
Fil | 57k | $2.4M | 561% | Mar 2024 |
|
Leucadia National Corporation | 49k | $2.1M | 100% | Mar 2024 |
|
Allspring Global Investments Holdings | 47k | $2.0M | -2% | Mar 2024 |
|
HighVista Strategies | 37k | $1.6M | -50% | Mar 2024 |
|
Marshall Wace | 35k | $1.5M | -67% | Mar 2024 |
|
Bank of America Corporation | 35k | $1.5M | -54% | Mar 2024 |
|
Boothbay Fund Management | 35k | $1.5M | 25% | Mar 2024 |
|
Wexford Capital | 33k | $1.4M | 0% | Mar 2024 |
|
Cutler | 31k | $1.3M | 37% | Mar 2024 |
|
TrueMark Investments | 30k | $1.3M | 14% | Mar 2024 |
|
Geode Capital Management | 29k | $1.2M | 271% | Mar 2024 |
|
AlphaCentric Advisors | 28k | $1.2M | 100% | Mar 2024 |
|
EFG Asset Management | 26k | $1.1M | 50% | Mar 2024 |
|
Jpmorgan Chase & Co | 24k | $1.0M | 211% | Mar 2024 |
|
Walleye Trading | 24k | $1.0M | -47% | Mar 2024 |
|
Simplex Trading | 23k | $984k | 86% | Mar 2024 |
|
Russell Investments | 22k | $931k | -24% | Mar 2024 |
|
Royal Bank of Canada | 22k | $921k | 229% | Mar 2024 |
|
J. Goldman & Co | 20k | $870k | 100% | Mar 2024 |
|
Nomura Asset Management | 18k | $762k | 100% | Mar 2024 |
|
FORA Capital | 17k | $733k | 100% | Mar 2024 |
|
M^T Bank Corporation | 16k | $690k | 10% | Mar 2024 |
|
Natixis Asset Management Advisors | 15k | $629k | -6% | Mar 2024 |
|
Squarepoint Ops | 14k | $593k | 100% | Mar 2024 |
|
Brandywine Managers | 12k | $515k | 9% | Mar 2024 |
|
Teachers Retirement System Of The State Of Kentucky | 12k | $475k | 100% | Dec 2023 |
|
NEOS Investment Management | 9.9k | $426k | 100% | Mar 2024 |
|
China Universal Asset Management | 9.4k | $402k | 116% | Mar 2024 |
|
LPL Financial | 8.8k | $377k | 100% | Mar 2024 |
|
Sofinnova Ventures | 8.7k | $374k | -96% | Mar 2024 |
|
Cubist Systematic Strategies | 8.7k | $372k | 100% | Mar 2024 |
|
Quadcap Wealth Management | 8.0k | $342k | 100% | Mar 2024 |
|
Jane Street | 7.7k | $329k | -80% | Mar 2024 |
|
Virtu Financial | 7.2k | $308k | 100% | Mar 2024 |
|
Qube Research & Technologies | 7.2k | $307k | 100% | Mar 2024 |
|
XTX Topco | 7.0k | $299k | 100% | Mar 2024 |
|
Gts Securities | 6.6k | $283k | 100% | Mar 2024 |
|
New York State Common Retirement Fund | 6.6k | $282k | -3% | Mar 2024 |
|
Bayesian Capital Management | 6.1k | $262k | 0% | Mar 2024 |
|
Envestnet Asset Management | 5.2k | $221k | 100% | Mar 2024 |
|
Bleichroeder | 5.0k | $204k | 100% | Dec 2023 |
|
Y-Intercept | 4.9k | $209k | 100% | Mar 2024 |
|
Verition Fund Management | 4.7k | $201k | 100% | Mar 2024 |
|
Sivik Global Healthcare | 4.5k | $191k | 100% | Mar 2024 |
|
ADAR1 Capital Management | 3.3k | $141k | -18% | Mar 2024 |
|
White Bay PT | 1.5k | $64k | 100% | Mar 2024 |
|
Virtus ETF Advisers | 1.5k | $63k | -6% | Mar 2024 |
|
Advisor Group Holdings | 1.4k | $62k | 19% | Mar 2024 |
|
North Star Investment Management | 880.00 | $38k | 0% | Mar 2024 |
|
Rhumbline Advisers | 450.00 | $19k | 0% | Mar 2024 |
|
Wells Fargo & Company | 446.00 | $19k | -39% | Mar 2024 |
|
Citigroup | 353.00 | $15k | -99% | Mar 2024 |
|
Tower Research Capital | 288.00 | $12k | -69% | Mar 2024 |
|
Daiwa Securities Group | 153.00 | $7.0k | 0% | Mar 2024 |
|
DeepCurrents Investment Group | 150.00 | $643k | 100% | Mar 2024 |
|
Planning Capital Management Corp | 140.00 | $6.0k | 0% | Mar 2024 |
|
Signature | 100.00 | $4.3k | 0% | Mar 2024 |
|
Private Trust Co Na | 71.00 | $3.0k | 238% | Mar 2024 |
|
Pnc Financial Services | 59.00 | $2.5k | 18% | Mar 2024 |
|
Hartland & Co | 59.00 | $2.4k | 69% | Dec 2023 |
|
Washington Trust Advisors | 41.00 | $1.8k | 0% | Mar 2024 |
|
Able Wealth Management | 14.00 | $570.999800 | 100% | Dec 2023 |
|
GAMMA Investing | 10.00 | $429.000000 | 11% | Mar 2024 |
|
Who sold out of Structure Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
MPM Oncology Impact Management | Sep 2023 | 231k | $12M |
Altium Capital Management | Sep 2023 | 155k | $7.8M |
Victory Capital Management | Dec 2023 | 125k | $5.1M |
Bamco | Dec 2023 | 118k | $4.8M |
Ing Investment Management | Sep 2023 | 87k | $4.4M |
GMT Capital Corp | Dec 2023 | 82k | $3.3M |
Exome Asset Management | Dec 2023 | 68k | $2.8M |
Weiss Multi-strategy Advisers | Dec 2023 | 49k | $2.0M |
Eudaimonia Asset Management | Sep 2023 | 44k | $2.2M |
Svb Financial Group | Sep 2023 | 35k | $1.8M |
Parkman Healthcare Partners | Sep 2023 | 30k | $1.5M |
E Fund Management | Dec 2023 | 29k | $1.2M |
Kennedy Capital Management | Dec 2023 | 26k | $1.1M |
Twinbeech Capital | Dec 2023 | 24k | $990k |
Ensign Peak Advisors | Sep 2023 | 16k | $822k |
Springbok Capital Management | Sep 2023 | 13k | $666k |
Schonfeld Strategic Advisors | Dec 2023 | 9.2k | $375k |
Raymond James & Associates | Dec 2023 | 5.7k | $233k |
Allianz Asset Management | Sep 2023 | 5.5k | $277k |
Picton Mahoney Asset Management | Dec 2023 | 2.4k | $98k |
Steward Partners Investment Advisory | Dec 2023 | 679.00 | $28k |